393
Participants
Start Date
August 30, 2018
Primary Completion Date
February 18, 2022
Study Completion Date
February 18, 2022
Dupilumab SAR231893 (REGN668)
"Pharmaceutical form: prefilled syringes~Route of administration: subcutaneous"
Investigational Site Number :032004, Buenos Aires
Investigational Site Number :032009, San Miguel de Tucumán
Investigational Site Number :710006, Durban
Investigational Site Number :710011, Cape Town
Investigational Site Number :710001, Cape Town
Investigational Site Number :710091, Cape Town
Investigational Site Number :710092, Cape Town
Investigational Site Number :056003, Ghent
Investigational Site Number :710009, Winnie Mandela
Investigational Site Number :276006, Berlin
Investigational Site Number :250001, Marseille
Investigational Site Number :840091, Pittsburgh
Investigational Site Number :276005, Rüdersdorf
Investigational Site Number :840067, Philadelphia
Investigational Site Number :840052, Chevy Chase
Investigational Site Number :840073, Gaithersburg
Investigational Site Number :840059, Fairfax
Investigational Site Number :276011, Großhansdorf
Investigational Site Number :840004, Papillion
Investigational Site Number :840907, High Point
Investigational Site Number :840126, Charlotte
Investigational Site Number :250009, Brest
Investigational Site Number :840055, Sarasota
Investigational Site Number :250002, Montpellier
Investigational Site Number :840115, Ocoee
Investigational Site Number :840032, Fort Mitchell
Investigational Site Number :840942, Toledo
Investigational Site Number :250005, Nantes
Investigational Site Number :840018, Minneapolis
Investigational Site Number :276009, Koblenz
Investigational Site Number :250010, Lille
Investigational Site Number :276010, Frankfurt am Main
Investigational Site Number :840102, St Louis
Investigational Site Number :250008, Strasbourg
Investigational Site Number :250006, Lyon
Investigational Site Number :840132, Little Rock
Investigational Site Number :840070, Allen
Investigational Site Number :840023, Dallas
Investigational Site Number :376002, Rehovot
Investigational Site Number :840922, Fort Worth
Investigational Site Number :840027, Fort Worth
Investigational Site Number :840124, Cypress
Investigational Site Number :840008, San Antonio
Investigational Site Number :840062, Amarillo
Investigational Site Number :840403, Denver
Investigational Site Number :840130, Denver
Investigational Site Number :840079, Twin Falls
Investigational Site Number :840035, Draper
Investigational Site Number :840077, Murray
Investigational Site Number :840099, Gilbert
Investigational Site Number :840087, Scottsdale
Investigational Site Number :840402, Tucson
Investigational Site Number :840121, San Jose
Investigational Site Number :840951, Bellingham
Investigational Site Number :376001, Kfar Saba
Investigational Site Number :376005, Petah Tikva
Investigational Site Number :840064, Bangor
Investigational Site Number :840068, West Long Branch
Investigational Site Number :840057, South Burlington
Investigational Site Number :032096, Bahía Blanca
Investigational Site Number :032091, Capital Federal
Investigational Site Number :032002, La Plata
Investigational Site Number :032006, Rosario
Investigational Site Number :032005, Rosario
Investigational Site Number :032003, Ciudad Autonoma Bs As
Investigational Site Number :032097, Ciudad Autonoma Buenos Aires
Investigational Site Number :032010, Ciudad Autonoma Buenos Aires
Investigational Site Number :032001, Ciudad Autonoma Buenos Aires
Investigational Site Number :032012, San Miguel de Tucumán
Investigational Site Number :124006, Vancouver
Investigational Site Number :124017, Vancouver
Investigational Site Number :124016, Hamilton
Investigational Site Number :124013, Ottawa
Investigational Site Number :124002, Toronto
Investigational Site Number :124010, Montréal
Investigational Site Number :124001, Montreal
Investigational Site Number :124012, Montreal
Investigational Site Number :124014, Québec
Investigational Site Number :124007, Trois-Rivières
Investigational Site Number :124018, Québec
Investigational Site Number :392106, Mizunami-shi
Investigational Site Number :392043, Ota-shi
Investigational Site Number :392021, Fukuyama-shi
Investigational Site Number :392108, Hiroshima
Investigational Site Number :392164, Muroran-shi
Investigational Site Number :392008, Sapporo
Investigational Site Number :392034, Sapporo
Investigational Site Number :392006, Tomakomai-shi
Investigational Site Number :392162, Kobe
Investigational Site Number :392020, Naka-gun
Investigational Site Number :392011, Sakaide-shi
Investigational Site Number :392014, Yokohama
Investigational Site Number :392153, Kyoto
Investigational Site Number :392170, Osaki-shi
Investigational Site Number :392045, Uruma
Investigational Site Number :392119, Kishiwada-shi
Investigational Site Number :392005, Naruto-shi
Investigational Site Number :392002, Chuo-ku
Investigational Site Number :392112, Chuo-ku
Investigational Site Number :392133, Machida-shi
Investigational Site Number :392177, Ome-shi
Investigational Site Number :392038, Setagaya-ku
Investigational Site Number :392167, Shinagawa-ku
Investigational Site Number :392173, Tachikawa-shi
Investigational Site Number :392185, Akashi-shi
Investigational Site Number :392007, Chūōku
Investigational Site Number :392012, Edogawa-ku
Investigational Site Number :392030, Habikino-shi
Investigational Site Number :392004, Himeji-shi
Investigational Site Number :392158, Hiroshima
Investigational Site Number :392013, Iizuka-shi
Investigational Site Number :392042, Isesaki-shi
Investigational Site Number :392142, Kasuga-shi
Investigational Site Number :392040, Kodaira-shi
Investigational Site Number :392044, Kokubunji-shi
Investigational Site Number :392010, Kurashiki-shi
Investigational Site Number :392036, Kyoto
Investigational Site Number :392144, Minatoku
Investigational Site Number :392122, Minatoku
Investigational Site Number :392163, Nagoya
Investigational Site Number :392155, Osakasayama-shi
Investigational Site Number :392152, Osakasayama-shi
Investigational Site Number :392127, Ōta-ku
Investigational Site Number :392169, Sagamihara-shi
Investigational Site Number :392130, Shinjuku-ku
Investigational Site Number :392165, Sumida-ku
Investigational Site Number :392146, Tachikawa-shi
Investigational Site Number :392029, Tsu
Investigational Site Number :392168, Uozu-shi
Investigational Site Number :392132, Urasoe-shi
Investigational Site Number :528001, Arnhem
Investigational Site Number :710007, Pretoria
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY